Gene-PUFA interactions and obesity risk

British Journal of Nutrition

Volumn 106, Issue 8, 2011, Pages 1263-1272

  Jourdan, C ^a   Kloiber, S ^b   Nieters, A ^c   Seiler, H ^d   Himmerich, H ^b,e   Kohli, M A ^b   Lucae, S ^b   Wolfram, G ^d   Gieger, C ^a   Wichmann, H E ^a,f,g   Linseisen, J ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF LEIPZIG   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Bavarian Food Consumption Survey II; Gene PUFA interactions; Nutritional biomarkers; Obesity

Indexed keywords

ADIPOCYTOKINE; ARACHIDONIC ACID; CYTOKINE; FATTY ACID; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 6; LEPTIN RECEPTOR; LINOLEIC ACID; NEUROTRANSMITTER; POLYUNSATURATED FATTY ACID; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DIET; ERYTHROCYTE MEMBRANE; FATTY ACID ANALYSIS; FEMALE; FOOD INTAKE; GENE INTERACTION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIPID COMPOSITION; MALE; OBESITY; PHYSICAL ACTIVITY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPOKINES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; CYTOKINES; FATTY ACIDS, UNSATURATED; FEMALE; GENE-ENVIRONMENT INTERACTION; GERMANY; HUMANS; INTERLEUKIN-6; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITION SURVEYS; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; YOUNG ADULT;

EID: 80054906005     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511001541     Document Type: Article

References (67)

1. Newell A, Zlot A, Silvey K, et al. (2007) Addressing the obesity epidemic: a genomics perspective. Prev Chronic Dis 4, A31.
2. Bell CG, Walley AJ & Froguel P (2005) The genetics of human obesity. Nat Rev Genet 6, 221-234. (Pubitemid 40293032)
3. Atwood LD, Heard-Costa NL, Cupples LA, et al. (2002) Genomewide linkage analysis of body mass index across 28 years of the Framingham Heart Study. Am J Hum Genet 71, 1044-1050. (Pubitemid 35305224)
4. Maes HH, Neale MC & Eaves LJ (1997) Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 27, 325-351. (Pubitemid 27415169)
5. Salsberry PJ & Reagan PB (2010) Effects of heritability, shared environment, and nonshared intrauterine conditions on child and adolescent BMI. Obesity (Silver Spring) 18, 1775-1780.
6. Peeters A, Beckers S, Verrijken A, et al. (2009) Possible role for ENPP1 polymorphism in obesity but not for INSIG2 and PLIN variants. Endocrine 36, 103-109.
7. Storlien LH, Huang XF, Lin S, et al. (2001) Dietary fat subtypes and obesity. World Rev Nutr Diet 88, 148-154. (Pubitemid 33210326)
8. Linseisen J, Schulze MB, Saadatian-Elahi M, et al. (2003) Quantity and quality of dietary fat, carbohydrate, and fiber intake in the German EPIC cohorts. Ann Nutr Metab 47, 37-46. (Pubitemid 36302363)
9. Harris WS, Lu G, Rambjor GS, et al. (1997) Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases. Am J Clin Nutr 66, 254-260. (Pubitemid 27360322)
10. Stulnig TM (2003) Immunomodulation by polyunsaturated fatty acids: mechanisms and effects. Int Arch Allergy Immunol 132, 310-321. (Pubitemid 38064930)
11. Jump DB (2004) Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 41, 41-78. (Pubitemid 38299789)
12. Pegorier JP, Le May C & Girard J (2004) Control of gene expression by fatty acids. J Nutr 134, 2444S-2449S. (Pubitemid 39201619)
13. Sampath H & Ntambi JM (2004) Polyunsaturated fatty acid regulation of gene expression. Nutr Rev 62, 333-339. (Pubitemid 39299134)
14. Storlien LH, Hulbert AJ & Else PL (1998) Polyunsaturated fatty acids, membrane function and metabolic diseases such as diabetes and obesity. Curr Opin Clin Nutr Metab Care 1, 559-563. (Pubitemid 128539489)
15. Iwaki M, Matsuda M, Maeda N, et al. (2003) Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52, 1655-1663. (Pubitemid 36792453)
16. Merzouk SA, Saker M, Reguig KB, et al. (2008) N-3 polyunsaturated fatty acids modulate in-vitro T cell function in type I diabetic patients. Lipids 43, 485-497.
17. Reseland JE, Haugen F, Hollung K, et al. (2001) Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res 42, 743-750. (Pubitemid 32509598)
18. Verlengia R, Gorjao R, Kanunfre CC, et al. (2003) Effect of arachidonic acid on proliferation, cytokines production and pleiotropic genes expression in Jurkat cells-a comparison with oleic acid. Life Sci 73, 2939-2951. (Pubitemid 37176886)
19. Alnajjar A, Chabane Sari D, Abuharfeil N, et al. (2006) Effect of n-3 and n-6 polyunsaturated fatty acids on lymphocyte proliferation, interleukin production and phospholipid fatty acids composition in type 2 diabetic and healthy subjects in Jordan people. Prostaglandins Leukot Essent Fatty Acids 74, 347-356. (Pubitemid 43816847)
20. Nieters A, Becker N & Linseisen J (2002) Polymorphisms in candidate obesity genes and their interaction with dietary intake of n-6 polyunsaturated fatty acids affect obesity risk in a sub-sample of the EPIC-Heidelberg cohort. Eur J Nutr 41, 210-221. (Pubitemid 36056319)
21. Bouchard C (1991) Current understanding of the etiology of obesity: genetic and nongenetic factors. Am J Clin Nutr 53, 1561S-1565S. (Pubitemid 21925693)
22. Arab L & Akbar J (2002) Biomarkers and the measurement of fatty acids. Public Health Nutr 5, 865-871.
23. Slimani N, Deharveng G, Charrondiere RU, et al. (1999) Structure of the standardized computerized 24-h diet recall interview used as reference method in the 22 centers participating in the EPIC project. European Prospective Investigation into Cancer and Nutrition. Comput Methods Programs Biomed 58, 251-266. (Pubitemid 29074674)
24. Slimani N, Ferrari P, Ocke M, et al. (2000) Standardization of the 24-hour diet recall calibration method used in the European prospective investigation into cancer and nutrition (EPIC): general concepts and preliminary results. Eur J Clin Nutr 54, 900-917. (Pubitemid 32036945)
25. Voss S, Charrondiere UR, Slimani N, et al. (1998) EPIC-SOFT a European computer program for 24-hour dietary protocols. Z Ernahrungswiss 37, 227-233. (Pubitemid 28459335)
26. (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894, i-xii 1-253.
27. Schaller N, Seiler H, Himmerich S, et al. (2005) Estimated physical activity in Bavaria, Germany, and its implications for obesity risk: results from the BVS-II Study. Int J Behav Nutr Phys Act 2, 6.
28. Golik A, Weissgarten J, Evans S, et al. (1996) Erythrocyte Na\+, K\+ and Ca2\+, Mg(2\+)-ATPase activities in hypertensives on angiotensin-converting enzyme inhibitors. Clin Biochem 29, 249-254.
29. Folch J, Lees M & Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509.
30. Wren JJ & Szczepanowksa AD (1964) Chromatography of lipids in presence of an antioxidant, 4-methyl-2,6-di-tertbutylphenol. J Chromatogr A 14, 387-404.
31. Butte W (1983) Rapid method for the determination of fatty acid profiles from fats and oils using trimethylsulphonium hydroxide for transesterification. J Chromatogr A 261, 142-145. (Pubitemid 13071468)
32. Hoff S, Seiler H, Heinrich J, et al. (2005) Allergic sensitisation and allergic rhinitis are associated with n-3 polyunsaturated fatty acids in the diet and in red blood cell membranes. Eur J Clin Nutr 59, 1071-1080. (Pubitemid 43118169)
33. Winkler J & Stolzenberg H (1999) Social class index in the Federal Health Survey. Gesundheitswesen 61, S178-S183.
34. Wigginton JE, Cutler DJ & Abecasis GR (2005) A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 76, 887-893. (Pubitemid 40563110)
35. Engstrom G, Hedblad B, Stavenow L, et al. (2003) Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes 52, 2097-2101. (Pubitemid 36919804)
36. Festa A, D'Agostino R Jr, Williams K, et al. (2001) The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25, 1407-1415. (Pubitemid 32977855)
37. Smith AJ & Humphries SE (2009) Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 20, 43-59.
38. von Schacky C (2007) n-3 PUFA in CVD: influence of cytokine polymorphism. Proc Nutr Soc 66, 166-170. (Pubitemid 46684970)
39. Calder PC & Grimble RF (2002) Polyunsaturated fatty acids, inflammation and immunity. Eur J Clin Nutr 56, Suppl. 3, S14-S19.
40. Gorjao R, Hirabara SM, de Lima TM, et al. (2007) Regulation of interleukin-2 signaling by fatty acids in human lymphocytes. J Lipid Res 48, 2009-2019. (Pubitemid 47360620)
41. Vozarova B, Weyer C, Hanson K, et al. (2001) Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 9, 414-417. (Pubitemid 33603868)
42. Himmerich H, Fulda S, Linseisen J, et al. (2006) TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population. Eur Cytokine Netw 17, 196-201.
43. Fishman D, Faulds G, Jeffery R, et al. (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102, 1369-1376. (Pubitemid 28467565)
44. Berthier MT, Paradis AM, Tchernof A, et al. (2003) The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. J Hum Genet 48, 14-19. (Pubitemid 36205641)
45. Kubaszek A, Pihlajamaki J, Punnonen K, et al. (2003) The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes 52, 558-561. (Pubitemid 36173216)
46. Huth C, Illig T, Herder C, et al. (2009) Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant-174G . C with circulating glucose levels, interleukin-6 levels, and body mass index. Ann Med 41, 128-138.
47. Qi L, Zhang C, van Dam RM, et al. (2007) Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26,944 individuals. J Clin Endocrinol Metab 92, 3618-3625. (Pubitemid 47435347)
48. Andersson N, Strandberg L, Nilsson S, et al. (2010) A variant near the interleukin-6 gene is associated with fat mass in Caucasian men. Int J Obes (Lond) 34, 1011-1019.
49. Thompson SR, Sanders J, Stephens JW, et al. (2007) A common interleukin 18 haplotype is associated with higher body mass index in subjects with diabetes and coronary heart disease. Metabolism 56, 662-669. (Pubitemid 46574729)
50. Skurk T, Kolb H, Muller-Scholze S, et al. (2005) The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur J Endocrinol 152, 863-868. (Pubitemid 40903576)
51. Hung J, McQuillan BM, Chapman CM, et al. (2005) Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol 25, 1268-1273. (Pubitemid 40776620)
52. Barbaux S, Poirier O, Godefroy T, et al. (2007) Differential haplotypic expression of the interleukin-18 gene. Eur J Hum Genet 15, 856-863. (Pubitemid 47109045)
53. Tiret L, Godefroy T, Lubos E, et al. (2005) Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 112, 643-650. (Pubitemid 41099042)
54. Suk K, Yeou Kim S & Kim H (2001) Regulation of IL-18 production by IFN gamma and PGE2 in mouse microglial cells: involvement of NF-kB pathway in the regulatory processes. Immunol Lett 77, 79-85. (Pubitemid 32480123)
55. Saltiel AR (2001)You arewhat you secrete. NatMed 7, 887-888.
56. Spiegelman BM & Flier JS (2001) Obesity and the regulation of energy balance. Cell 104, 531-543. (Pubitemid 32201948)
57. Arita Y, Kihara S, Ouchi N, et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257, 79-83. (Pubitemid 29299050)
58. Hu E, Liang P & Spiegelman BM (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271, 10697-10703. (Pubitemid 26145805)
59. Chuang LM, Chiu YF, Sheu WH, et al. (2004) Biethnic comparisons of autosomal genomic scan for loci linked to plasma adiponectin in populations of Chinese and Japanese origin. J Clin Endocrinol Metab 89, 5772-5778. (Pubitemid 39518470)
60. Comuzzie AG, Funahashi T, Sonnenberg G, et al. (2001) The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 86, 4321-4325. (Pubitemid 32848553)
61. Vasseur F, Helbecque N, Dina C, et al. (2002) Singlenucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11, 2607-2614. (Pubitemid 35174690)
62. Itoh M, Suganami T, Satoh N, et al. (2007) Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol 27, 1918-1925. (Pubitemid 47315642)
63. Flachs P, Mohamed-Ali V, Horakova O, et al. (2006) Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 49, 394-397. (Pubitemid 43185410)
64. Yu YH, Lin EC, Wu SC, et al. (2008) Docosahexaenoic acid regulates adipogenic genes in myoblasts via porcine peroxisome proliferator-activated receptor gamma. J Anim Sci 86, 3385-3392.
65. Lorente-Cebrian S, Perez-Matute P, Martinez JA, et al. (2006) Effects of eicosapentaenoic acid (EPA) on adiponectin gene expression and secretion in primary cultured rat adipocytes. J Physiol Biochem 62, 61-69.
66. Phillips CM, Goumidi L, Bertrais S, et al. (2010) Leptin receptor polymorphisms interact with polyunsaturated fatty acids to augment risk of insulin resistance and metabolic syndrome in adults. J Nutr 140, 238-244.
67. Colhoun HM, McKeigue PM & Davey Smith G (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361, 865-872. (Pubitemid 36331853)